← Back to Clinical Trials
Recruiting Phase 4 NCT06991972
Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients
Trial Parameters
Condition Vitiligo
Sponsor Khyber Teaching Hospital
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 80
Sex ALL
Min Age 15 Years
Max Age 60 Years
Start Date 2025-03-01
Completion 2025-08-31
All Conditions
Interventions
Needling + NBUVBMicroneedling + NBUVB
Brief Summary
This randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.
Eligibility Criteria
Inclusion Criteria: * Both male and female * Age 15-60 years * Patients having vitiligo for more than 1 year Exclusion Criteria: * Patients with tendency of keloid formation or hypertrophic scarring * Patients with any bleeding disorder, coagulation defect or using anti platelets * Any local infection at the treatment site * Patients who had received systemic therapy in last 6 months
Related Trials
NCT06719024
Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacro
View Trial →
NCT06991972
Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients
View Trial →
NCT06602232
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
View Trial →